Vasopressin reduces taurochenodeoxycholate-induced hepatotoxicity by lowering the hepatocyte taurochenodeoxycholate content

This publication has 20 references indexed in Scilit:

• Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts
  Gastroenterology, 1994
• Molecular aspects of membrane stabilization by ursodeoxycholate
  Gastroenterology, 1993
• Effects of Dibutyryl Cyclic AMP and Papaverine on Intrahepatocytic Bile Acid Transport Role of Vesicle Transport
  Scandinavian Journal of Gastroenterology, 1993
• Papaverine Inhibits Transcytotic Vesicle Transport and Lipid Excretion Into Bile in Isolated Perfused Rat Liver
  Hepatology, 1992
• Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes
  Hepatology, 1991
• Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial
  Gastroenterology, 1989
• Effect of vasodilators on hepatic microcirculation: A study of the inhibition of norepinephrine-induced vasoconstriction in the isolated perfused rat liver
  Hepatology, 1988
• IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?
  The Lancet, 1987
• A NEW ANALYTICAL METHOD OF INDIVIDUAL BILE ACIDS USING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY AND IMMOBILIZED 3α-HYDROXYSTEROID DEHYDROGENASE IN COLUMN FORM
  Chemistry Letters, 1979
• Choleretic and cholestatic effects of infused bile salts in the rat
  Cellular and Molecular Life Sciences, 1979